title: Mode of action of dopamine in inducing hyperglycemia in the fresh water edible crab, Oziothelphusa senex senex.
abstract: The objective of this study was to investigate the mode of action of dopamine in regulating hemolymph sugar level in the fresh water edible crab, Oziothelphusa senex senex. Injection of dopamine produced hyperglycemia in a dose-dependent manner in intact crabs but not in eyestalkless crabs. Administration of dopamine resulted in a significant decrease in total carbohydrates and glycogen levels with a significant increase in glycogen phosphorylase activity levels in hepatopancreas and muscle of intact crabs, indicating dopamine-induced glycogenolysis resulting in hyperglycemia. Bilateral eyestalk ablation resulted in significant increase in the total carbohydrates and glycogen levels with a significant decrease in the activity levels of phosphorylase in the hepatopancreas and muscle of the crabs. Eyestalk ablation resulted in significant decrease in hemolymph hyperglycemic hormone levels. The levels of hyperglycemic hormone in the hemolymph of dopamine injected crabs were significantly higher than in control crabs. However, no significant changes in the levels of hemolymph hyperglycemic hormone and sugar and tissue carbohydrate and phosphorylase activity were observed in dopamine injected eyestalk ablated crabs when compared with eyestalk ablated crabs. These results support an earlier hypothesis in crustaceans that dopamine acts as a neurotransmitter and induces hyperglycemia by triggering the release of hyperglycemic hormone in the crab, O. senex senex.
authors: Department of Biotechnology, Sri Venkateswara University, Tirupati, India.
authors: Ch
authors: Ch
authors: Swetha
authors: S B
authors: SB
authors: Sainath
authors: P Sreenivasula
authors: PS
authors: Reddy
mesh_terms: D000818:Animals; D003386:Brachyura / Q000187:drug effects / Q000378:metabolism*; D050260:Carbohydrate Metabolism; D004298:Dopamine / Q000008:administration & dosage / Q000378:metabolism*; D056145:Freshwater Biology; D006003:Glycogen / Q000378:metabolism; D006458:Hemolymph / Q000187:drug effects / Q000378:metabolism; D006943:Hyperglycemia / Q000378:metabolism* / Q000473:pathology; D018377:Neurotransmitter Agents / Q000378:metabolism*
chemical_list: D018377:Neurotransmitter Agents; D006003:Glycogen; D004298:Dopamine